SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Attention is centered on reports that Papa Johns largest U.S. franchisee has joined Irth Capitals effort to take the company private, reviving buyout hopes. Traders see the franchisees involvement as strengthening the proposal, while others remain skeptical that the board will approve a deal or that negotiations will produce a signed transaction.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Phase 3 results for Amgens IMDELLTRA-plus-IMFINZI combination in extensive-stage small-cell lung cancerreported to reduce the risk of death by 58%are driving discussion, with traders viewing the data as a potential growth opportunity. Some also point to Repathas sales growth as a key business driver and debate whether the lung-cancer program can become a major contributor.

TOSHI

TOSHI is drawing attention around a hoped-for breakout after bursts of volume and a modest rebound, with traders repeatedly watching a stubborn resistance zone and speculating about a short squeeze. Bulls are accumulating and anticipating a run, while skeptics point to repeated rejections, weak price action, and broader crypto-market risk; rumors of listings or an announcement remain unconfirmed.

Palo Alto Networks, is a cybersecurity company that provides cybersecurity platforms and services to enterprises, organizations, service providers, and government entities. Its offerings include network and AI security, cloud security, security operations, and identity security solutions. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks rallied with cybersecurity peers as traders focused on an Evercore ISI survey indicating enterprise security budgets are firming and on escalating vulnerability and AI-driven cyberthreat concerns. The move drew bullish momentum commentary, while some traders questioned whether the sectors gains are justified given lofty valuations.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Updated ESMO subgroup analyses from Celcuitys Phase 3 VIKTORIA-1 breast-cancer study are driving discussion, with traders highlighting favorable efficacy for gedatolisib and the potential for a PIK3CA-mutant label expansion. The reaction is split between enthusiasm for the data and concern that CELC still needs to demonstrate commercial uptake and revenue; some posts also debate whether the share price reflects the clinical results.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

A broad biotech-sector pullback is the main focus, with IBB hovering near its 50-day moving average after a strong run. Traders describe the dip as a pause while others remain cautious about sector weakness, and several note that large-cap biotech is holding up better than smaller names.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare shares are drawing attention after a sharp gain tied to the PHP2Shell web-software vulnerabilities: traders see its web application firewall as a potential beneficiary as site operators seek protection, alongside a broader cybersecurity-stock rally. Some participants are bullish on the security-demand angle, while others focus on the stocks high valuation and trade the move cautiously.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Attention centers on Merck and Modernas Phase 3 melanoma-vaccine results: the personalized vaccine combined with Keytruda met trial endpoints, but traders debate whether the benefit and future commercial potential justify expectations, with some viewing the share pullback as a sell the news reaction. The treatment is not yet approved, and its broader use remains uncertain.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

Promising lung-cancer trial updates for BioNTechs oncology pipeline, including pumitamig and gotistobart, are drawing attention, with traders highlighting encouraging response and survival data. The reaction is bullish but tempered by questions about how durable the results are and lingering concerns over earlier clinical setbacks and leadership changes.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEOs sale of its Adelanto facilities to DHS and the resulting debt-reduction and buyback flexibility are driving discussion. Traders see the transaction as a balance-sheet positive, while others question the stocks weakness and weigh the benefits against giving up ownership economics; many are looking for clarity on further sales.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Invesco Closed-End Funds Declare Dividends

Invesco Closed-End Funds Declare Dividends Invesco Closed-End Funds Declare Dividends PR Newswire ATLANTA, May 1, 2026 ATLANTA, May 1, 2026 /PRNewswire/ -- The Board of Trustees of each of the...

Invesco Closed-End Funds Declare Dividends Invesco Closed-End Funds Declare Dividends PR Newswire ATLANTA, April 1, 2026 ATLANTA, April 1, 2026 /PRNewswire/ --The Board of Trustees of each of the...

Invesco Closed-End Funds Declare Dividends Invesco Closed-End Funds Declare Dividends PR Newswire ATLANTA, March 2, 2026 ATLANTA, March 2, 2026 /PRNewswire/ -- The Board of Trustees of each of the...

Invesco Advantage Municipal Income Trust II is a closed-end investment fund and trust. Its investment objective is to seek to provide a high level of current income exempt from federal income tax, consistent with preservation of capital. The company was founded in 1993 and is headquartered in Atlanta, GA.

Invesco Advantage Municipal Income Trust II

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$8.11
Prev Close	$8.26
Open	$8.27
Dividend Yield	7.17%
50-Day Moving Average	$8.32
Beta	0.29
Avg. Volume	193,073.29
PE Ratio	32.57

52-Week High	$9.60
52-Week Low	$7.25
Market Capitalization	$360.13M
EPS (Annual)	$0.249
Price to Book	0.89
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

VKI Fundamentals